Author/Authors :
Iakovou، نويسنده , , Ioannis and Dangas، نويسنده , , George and Mintz، نويسنده , , Gary S. and Mehran، نويسنده , , Roxana and Lansky، نويسنده , , Alexandra J. and Aymong، نويسنده , , Eve D. and Nikolsky، نويسنده , , Eugenia and Vagaonescu، نويسنده , , Tudor and Glasser، نويسنده , , Lynne A. and Stone، نويسنده , , Gregg W. and Leon، نويسنده , , Martin B. and Moses، نويسنده , , Jeffrey W.، نويسنده ,
Abstract :
We identified 1,369 consecutive patients who received glycoprotein IIb/IIIa inhibitors during 1,461 stenting procedures (2,382 lesions); of these, 240 (17.5%) were aged ≥75 years (253 procedures, 430 lesions). Very elderly patients (≥75 years) had similar in-hospital outcomes but a higher hemorrhagic stroke rate than patients aged <75 years.
